Innate Pharma S.A. IPHA
Set alert
1.34 USD -0.06 -4.29%
As of Nov 3, 11:59 AM ET
1.34 Day range 1.35
1.17 52-week range 2.71
- YTD
- -23.43%
- 1 year
- -29.47%
- Open
- 1.35
- Prev close
- 1.40
- Mkt cap
- 149.68M
- Vol
- 61.09K
- Avg vol
- 159.13K
- EPS
- -0.59
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.34
- High
- 1.35
- Forward P/E
- 4.67
- Beta
- 0.87
- Short ratio
- 5.63
- Inst. own
- 0.50%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Mar 21, 2024
- 50-d avg
- 1.82
- 200-d avg
- 2.23
- 1y target
- 7.41
MAX chart
Events in this range
- Mar 18, 2021Earnings: —; estimate 0; surprise —%
- Mar 24, 2022Earnings: —; estimate 0; surprise —%
- Mar 23, 2023Earnings: —; estimate 0; surprise —%
- Mar 21, 2024Earnings: —; estimate 0; surprise —%
- May 15, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Jun 12, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Sep 13, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Nov 12, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Nov 15, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Dec 9, 2024Rating: HC Wainwright & Co. · Buy → Buy
Signals (142)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Sep 21, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 21, 2026 | 1 month ago |
| SMA: Bearish | Sep 7, 2026 | 1 month ago |
| SMA: Bullish | Aug 10, 2026 | 2 months ago |
| SMA: Bearish | Jul 13, 2026 | 3 months ago |
| SMA: Bullish | May 11, 2026 | 5 months ago |
| SMA: Bullish | May 11, 2026 | 5 months ago |
| MACD: Buy Signal | May 11, 2026 | 5 months ago |
| SMA: Bearish | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| RSI: Oversold | Mar 16, 2026 | 7 months ago |
| SMA: Bearish | Feb 2, 2026 | 9 months ago |
| SMA: Bullish | Jan 26, 2026 | 9 months ago |
| MACD: Sell Signal | Nov 3, 2025 | 1 year ago |
| SMA: Bearish | Oct 27, 2025 | 1 year ago |
| SMA: Bearish | Oct 27, 2025 | 1 year ago |
| SMA: Bullish | Oct 13, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 13, 2025 | 1 year ago |
| SMA: Bullish | Sep 29, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 15, 2025 | 1 year ago |
Newest 20 of 142.
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 9.01M | 20.12M | 61.64M | 57.67M | 24.70M | |
| 9.01M | 20.12M | 61.64M | 57.67M | 24.70M | |
| -54.01M | -51.58M | -12.67M | -57.42M | -47.83M | |
| -49.18M | -49.47M | -7.57M | -58.10M | -52.81M | |
| -0.55 | -0.61 | -0.09 | -0.73 | -0.66 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 28.09M | 66.40M | 70.61M | 84.22M | 103.76M | |
| 62.72M | 111.06M | 175.19M | 199.29M | 267.50M | |
| 84.42M | 102.22M | 123.29M | 145.14M | 160.06M | |
| 22.57M | 31.00M | 39.89M | 42.25M | 44.25M | |
| -21.70M | 8.83M | 51.90M | 54.15M | 107.44M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -52.76M | -6.90M | -32.56M | -19.16M | -58.46M | |
| 7.29M | 9.20M | 20.63M | 1.88M | -917.00K | |
| 6.07M | -6.01M | -1.97M | -1.83M | 26.82M | |
| -140.00K | -391.00K | -201.00K | -535.00K | -922.00K | |
| -38.30M | -4.21M | -13.62M | -19.53M | -33.04M |